Intravenous beta-adrenoblocker therapy in acute coronary syndrome patients

Early treatment optimization improves clinical outcomes and reduces morbidity and mortality in patients with acute myocardial infarction (AMI). Intravenous beta-adrenoblocker (BAB) therapy, associated with improved survival, is well tolerated by AMI patients. The results of relevant clinical trials...

Full description

Bibliographic Details

Published in:	Кардиоваскулярная терапия и профилактика
Main Authors:	S. N. Tereshchenko, I. V. Zhirov
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 1970-01-01
Subjects:	acute myocardial infarction beta-adrenoblockers cardiogenic shock genetic polymorphism
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/1497